ZYMEWORKS INC. Shares Outstanding (Cover Page)
ZYMEWORKS INC. (ZYME) had Shares Outstanding (Cover Page) of 70.96 million shares as of 2026-08-04, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-04: Entity Common Stock, Shares Outstanding 70.96M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 73.02M shares.
- 2026-02-26: Entity Common Stock, Shares Outstanding 73.75M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 74.84M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 70.96M shares 10-Q · filed 2026-08-06 |
| 2026-05-06 | 73.02M shares 10-Q · filed 2026-05-07 |
| 2026-02-26 | 73.75M shares 10-K · filed 2026-03-02 |
| 2025-11-04 | 74.84M shares 10-Q · filed 2025-11-06 |
| 2025-08-05 | 75.17M shares 10-Q · filed 2025-08-07 |
| 2025-05-06 | 69.68M shares 10-Q · filed 2025-05-08 |
| 2025-03-03 | 69.58M shares 10-K · filed 2025-03-05 |
| 2024-10-30 | 68.88M shares 10-Q · filed 2024-10-31 |
| 2024-07-31 | 71.05M shares 10-Q · filed 2024-08-01 |
| 2024-04-30 | 70.70M shares 10-Q · filed 2024-05-02 |
| 2024-03-04 | 70.57M shares 10-K · filed 2024-03-06 |
| 2023-11-06 | 70.00M shares 10-Q · filed 2023-11-07 |
| 2023-08-09 | 67.83M shares 10-Q · filed 2023-08-10 |
| 2023-05-03 | 64.17M shares 10-Q · filed 2023-05-08 |
| 2023-04-15 | 64.14M shares 10-K/A · filed 2023-04-28 |
| 2023-03-03 | 64.04M shares 10-K · filed 2023-03-07 |
| 2022-11-04 | 63.00M shares 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |